Financials
- Market Capitalization 1.91 B
- Employee 161
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-33.72
市销率
10.53
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2016 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.80 USD | +0.73% | +2.98% | +34.69% | +109.47% | 1.94 B USD | ||
| 2028 | TYRA Tyra Biosciences, Inc. - Common Stock | 32.63 USD | -0.12% | +3.06% | +20.01% | +127.55% | 1.94 B USD | ||
| 2051 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.32 USD | +2.30% | -22.20% | +4.23% | -2.92% | 1.86 B USD | ||
| 2054 | BCAX Bicara Therapeutics Inc. - Common Stock | 28.35 USD | +0.71% | -6.96% | +29.27% | +96.33% | 1.86 B USD |